Five-year Results of a Randomized Trial with Open-label Extension of Triamcinolone Acetonide for Refractory Diabetic Macular Edema

Ophthalmology

Volumn 116, Issue 11, 2009, Pages 2182-2187

  Gillies, Mark C ^a   Simpson, Judy M ^b   Gaston, Christine ^a   Hunt, Grace ^a   Ali, Haipha ^a   Zhu, Meidong ^a   Sutter, Florian ^c  

^a UNIVERSITY OF SYDNEY   (Australia)

^b UNIVERSITY OF SYDNEY   (Australia)

^c UNIVERSITY HOSPITAL ZURICH   (Switzerland)

Author keywords

[No Author keywords available]

Indexed keywords

PLACEBO; TRIAMCINOLONE ACETONIDE;

ARTICLE; CATARACT EXTRACTION; CLINICAL ARTICLE; CLINICAL TRIAL; CONTROLLED CLINICAL TRIAL; CONTROLLED STUDY; DIABETIC MACULAR EDEMA; DOUBLE BLIND PROCEDURE; DRUG SAFETY; ENDOPHTHALMITIS; HUMAN; INTRAOCULAR PRESSURE; LASER SURGERY; PRIORITY JOURNAL; RANDOMIZED CONTROLLED TRIAL; RECURRENT DISEASE; RETINA FOVEA; RETREATMENT; RISK REDUCTION; SIDE EFFECT; TRABECULECTOMY; VISUAL ACUITY; VISUAL IMPAIRMENT;

DIABETIC RETINOPATHY; DOUBLE-BLIND METHOD; GLUCOCORTICOIDS; HUMANS; INJECTIONS; MACULAR EDEMA; PROSPECTIVE STUDIES; TREATMENT OUTCOME; TRIAMCINOLONE ACETONIDE; VISUAL ACUITY; VITREOUS BODY;

EID: 70350574742     PISSN: 01616420     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.ophtha.2009.04.049     Document Type: Article

References (10)

1. Gillies M.C., Sutter F.K., Simpson J.M., et al. Intravitreal triamcinolone for refractory diabetic macular edema: two-year results of a double-masked, placebo-controlled, randomized clinical trial. Ophthalmology 113 (2006) 1533-1538
2. Jonas J.B., and Söfker A. Intraocular injection of crystalline cortisone as adjunctive treatment of diabetic macular edema. Am J Ophthalmol 132 (2001) 425-427
3. Massin P., Audren F., Haouchine B., et al. Intravitreal triamcinolone acetonide for diabetic diffuse macular edema: preliminary results of a prospective controlled trial. Ophthalmology 111 (2004) 218-224
4. Sutter F.K., Simpson J.M., and Gillies M.C. Intravitreal triamcinolone for diabetic macular edema that persists after laser treatment: three-month efficacy and safety results of a prospective, randomized, double-masked, placebo-controlled clinical trial. Ophthalmology 111 (2004) 2044-2049
5. Mohamed Q., Gillies M.C., and Wong T.Y. Management of diabetic retinopathy: a systematic review. JAMA 298 (2007) 902-916
6. Age-Related Eye Disease Study Research Group. The Age-Related Eye Disease Study (AREDS) system for classifying cataracts from photographs: AREDS report no. 4. Am J Ophthalmol 131 (2001) 167-175
7. Hollis S., and Campbell F. What is meant by intention to treat analysis?. Survey of published randomised controlled trials. BMJ 319 (1999) 670-674
8. Zeger S.L., Liang K.Y., and Albert P.S. Models for longitudinal data: a generalized estimating equation approach. Biometrics 44 (1988) 1049-1060
9. Gillies M.C., Simpson J.M., Zhu M., et al. Intravitreal triamcinolone [letter]. Ophthalmology 116 (2009) 591
10. Diabetic Retinopathy Clinical Research Network. A randomized trial comparing intravitreal triamcinolone acetonide and focal/grid photocoagulation for diabetic macular edema. Ophthalmology 115 (2008) 1447-1459